- Home
- OPBK vs SCPH Comparison
OPBK vs SCPH Comparison
Compare OPBK & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- SCPH
- Stock Information
- Founded
- OPBK 2005
- SCPH 2013
- Country
- OPBK United States
- SCPH United States
- Employees
- OPBK N/A
- SCPH N/A
- Industry
- OPBK Major Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OPBK Finance
- SCPH Health Care
- Exchange
- OPBK Nasdaq
- SCPH Nasdaq
- Market Cap
- OPBK 257.1M
- SCPH 274.7M
- IPO Year
- OPBK 2018
- SCPH 2017
- Fundamental
- Price
- OPBK $16.21
- SCPH $3.14
- Analyst Decision
- OPBK Hold
- SCPH Strong Buy
- Analyst Count
- OPBK 1
- SCPH 2
- Target Price
- OPBK $13.00
- SCPH $15.00
- AVG Volume (30 Days)
- OPBK 25.5K
- SCPH 404.8K
- Earning Date
- OPBK 01-23-2025
- SCPH 11-13-2024
- Dividend Yield
- OPBK 2.80%
- SCPH N/A
- EPS Growth
- OPBK N/A
- SCPH N/A
- EPS
- OPBK 1.40
- SCPH N/A
- Revenue
- OPBK $78,759,000.00
- SCPH $30,278,000.00
- Revenue This Year
- OPBK N/A
- SCPH $174.12
- Revenue Next Year
- OPBK $12.64
- SCPH $133.41
- P/E Ratio
- OPBK $11.28
- SCPH N/A
- Revenue Growth
- OPBK N/A
- SCPH 303.87
- 52 Week Low
- OPBK $8.91
- SCPH $3.08
- 52 Week High
- OPBK $18.57
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- OPBK 52.12
- SCPH 36.30
- Support Level
- OPBK $16.75
- SCPH $3.16
- Resistance Level
- OPBK $17.36
- SCPH $3.67
- Average True Range (ATR)
- OPBK 0.56
- SCPH 0.23
- MACD
- OPBK -0.20
- SCPH -0.01
- Stochastic Oscillator
- OPBK 14.80
- SCPH 4.35
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.